Printer Friendly

ELAN'S SMOKING CESSATION PRODUCT -- FIRST OTC LAUNCH

 ELAN'S SMOKING CESSATION PRODUCT -- FIRST OTC LAUNCH
 ATHLONE, Ireland, Jan. 24 /PRNewswire/ -- Elan Corporation


(AMEX: ELN) today announced that its once daily smoking cessation patch has been launched for over the counter sales in Italy under the brand name Nicotrans.
 Elan's marketing partner in Italy is Recordati Industria Chimica E. Farmaceutica S.p.A.
 In commenting on the launch, Donald E. Panoz, chairman and CEO of Elan stated that "this approval and launch of Nicotrans is an endorsement of the safety and efficiency of Elan's product which has a nicotine loading of 30 mg and 75 percent utilization compared to similar products which have a nicotine loading of up to 114 mg and only a 25 percent utilization."
 Elan's nicotine patch delivers 22 mg nicotine over a 24 hour period and reduces the craving for nicotine which smokers experience when trying to quit smoking.
 Elan Corporation plc is a leader in the specialized health care field of advanced reformulation and drug delivery, concentrating on improved drug absorption and utilization. Elan operates research and manufacturing facilities in Athlone, Republic of Ireland; Gainesville, Ga.; Enschede, Netherlands; Manila, Philippines; Brea, Calif. and Cambridge, Mass.
 -0- 1/24/92
 /CONTACT: Brian Crotty of Elan, in Athlone: 0902-94666, or Thomas Redington of Redington Inc., 212-926-1733, for Elan/
 (ELN) CO: Elan Corporation ST: IN: MTC SU:


SH-TS -- NY020 -- 3180 01/24/92 10:11 EST
COPYRIGHT 1992 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Jan 24, 1992
Words:229
Previous Article:AMERICANS WITH DISABILITIES COULD COST BILLIONS FOR HOSPITALS
Next Article:PONTIAC DIVISION REPORTS SALES INCREASE
Topics:


Related Articles
MARION MERRELL DOW INTRODUCES FIRST NICOTINE PATCH FOR SMOKING CESSATION THERAPY
U.S. FDA APPROVES ELAN'S NICOTINE PATCH
/FIRST ADD -- NY081 -- ELAN'S NICOTINE PATCH APPROVED BY FDA/
ELAN STEPS UP PROSTEP PATCH PRODUCTION FOR CYANAMID'S LEDERLE; MORE THAN FOUR MILLION SHIPPED THUS FAR
ELAN ADDS $200 MILLION OF NICOTINE PATCH PRODUCTION CAPACITY WITH SECOND UNIT; U.S. MARKET SHARE NOW AT 30 PERCENT
LEDERLE ANNOUNCES PROSTEP NOW FULLY AVAILABLE; NATIONAL ADVERTISING BEGINS ON THE OLYMPICS THIS WEEK
CIBA TO TRANSFER MARKETING OF NICOTINE PATCH TO CONSUMER UNIT
SMITHKLINE BEECHAM'S NICORETTE HITS THE SHELVES; FIRST FDA-APPROVED OVER-THE-COUNTER STOP SMOKING AID
GOVERNMENT PANEL UNANIMOUSLY RECOMMENDS NICODERM APPROVAL FOR OVER-THE-COUNTER STATUS
IN RESPONSE TO MEDIA INQUIRIES REGARDING THE MARKETING APPROVAL OF NICOTROL, SMITHKLINE BEECHAM ISSUED THE FOLLOWING STATEMENT:

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters